ghk-cu injection clinical trial Frontiers ghk-cu clinical trial injection GHK-Cu

Who is not a candidate for B12 injections

10.1371/journal.pone.0069351 PLoS One 19 JiangX

The present invention solves these problems by providing BPC peptide salts and a pharmaceutical or diagnostic composition comprising a pharmaceutically or diagnostically effective amount of the salts of BPC peptides said peptides being constituted of 8 to 15 amino acids, wherein the anion of the salt is a negatively charged peptide comprising 8 amino acid residues having the general formula (I) Yaa is a basic amino acid residue, in particular Lys, Arg, Orn or His and Zaa is an acidic amino acid residue, in particular Glu, Asp, Aad or Apm and wherein the cation of the salt is the cation of an inorganic or organic nontoxic and pharmaceutically acceptable base

(Study: Zinman et al., 2019) Administration: Mounjaro is administered orally, typically once daily, making it convenient for patients

enteric-coated versions offer some protection from gastric degradation Liquid / sublingual drops faster mucosal contact

Option 2: Full reconstitution with portion freezing Reconstitute the entire 100mg vial, then immediately divide into multiple sterile vials